Literature DB >> 29482778

A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors.

Bhanu Prasad Venkatesulu1, Supriya Mallick2, Steven H Lin3, Sunil Krishnan4.   

Abstract

Lymphopenia is a common accompaniment of multimodal cancer therapy. As the most radiosensitive cells of the hematopoietic system, lymphocytes residing within or circulating through a radiation portal are frequently depleted by radiation therapy. The recognition that radiation-induced reduction of circulating lymphocyte counts and eventual lymphocyte infiltration of tumors have a tangible impact on overall survival outcomes has revived the interest in understanding the causes of treatment-associated lymphopenia and developing strategies to predict, prevent and ameliorate this well-documented phenomenon. In this systematic review, we have performed a comprehensive search of the literature to elucidate the studies that document a correlation between radiation-associated lymphopenia and survival outcomes in solid malignancies. We also summarize potential unifying paradigms that account for radiation-induced lymphopenia across studies and lay the groundwork for attempting to explain and/or counter this phenomenon.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Lymphopenia; Radiation; Systematic review

Mesh:

Year:  2018        PMID: 29482778     DOI: 10.1016/j.critrevonc.2018.01.003

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  83 in total

1.  Harnessing radiation to improve immunotherapy: better with particles?

Authors:  Marco Durante; Silvia Formenti
Journal:  Br J Radiol       Date:  2019-07-22       Impact factor: 3.039

2.  Proton minibeams-a springboard for physics, biology and clinical creativity.

Authors:  F Avraham Dilmanian; Bhanu P Venkatesulu; Narayan Sahoo; Xiaodong Wu; Jessica R Nassimi; Steven Herchko; Jiade Lu; Bilikere S Dwarakanath; John G Eley; Sunil Krishnan
Journal:  Br J Radiol       Date:  2020-01-24       Impact factor: 3.039

3.  A novel deep learning model using dosimetric and clinical information for grade 4 radiotherapy-induced lymphopenia prediction.

Authors:  Cong Zhu; Steven H Lin; Xiaoqian Jiang; Yang Xiang; Zayne Belal; Goo Jun; Radhe Mohan
Journal:  Phys Med Biol       Date:  2020-02-04       Impact factor: 3.609

4.  Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab.

Authors:  Nalee Kim; Jeong Il Yu; Hee Chul Park; Gyu Sang Yoo; Changhoon Choi; Jung Yong Hong; Ho Yeong Lim; Jeeyun Lee; Moon Seok Choi; Jung Eun Lee; Kyunga Kim
Journal:  Cancer Immunol Immunother       Date:  2020-11-24       Impact factor: 6.968

5.  Systemic Inflammation After Radiation Predicts Locoregional Recurrence, Progression, and Mortality in Stage II-III Triple-Negative Breast Cancer.

Authors:  Alexander D Sherry; Rie von Eyben; Neil B Newman; Paulina Gutkin; Ingrid Mayer; Kathleen Horst; A Bapsi Chakravarthy; Marjan Rafat
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-12-03       Impact factor: 7.038

6.  Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15-18 October 2017; Cancun, Mexico.

Authors:  Kelly C Falls; Ricky A Sharma; Yaacov R Lawrence; Richard A Amos; Sunil J Advani; Mansoor M Ahmed; Bhadrasain Vikram; C Norman Coleman; Pataje G Prasanna
Journal:  Radiat Res       Date:  2018-10       Impact factor: 2.841

7.  Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.

Authors:  Tetsuo Saito; Ryo Toya; Naoya Yoshida; Takashi Shono; Tomohiko Matsuyama; Satoshi Ninomura; Takahiro Watakabe; Yutaka Sasaki; Hideo Baba; Natsuo Oya
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

Review 8.  Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists.

Authors:  Alice Y Ho; Jean L Wright; Rachel C Blitzblau; Robert W Mutter; Dan G Duda; Larry Norton; Aditya Bardia; Laura Spring; Steven J Isakoff; Jonathan H Chen; Clemens Grassberger; Jennifer R Bellon; Sushil Beriwal; Atif J Khan; Corey Speers; Samantha A Dunn; Alastair Thompson; Cesar A Santa-Maria; Ian E Krop; Elizabeth Mittendorf; Tari A King; Gaorav P Gupta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-05-14       Impact factor: 7.038

Review 9.  Proton therapy for non-small cell lung cancer: the road ahead.

Authors:  Eric D Brooks; Matthew S Ning; Vivek Verma; X Ronald Zhu; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2019-09

10.  Association Between Radiation Tolerance of Lymphocytes and Clinical Outcomes in Cervical Cancer.

Authors:  Shiho Lee; Oyeon Cho; Mison Chun; Suk Jun Chang; Tae Wook Kong; Eun Ju Lee; Yonghee Lee
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.